PAVmed (PAVM) vs SiNtx Technologies (SINT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
SiNtx Technologies (SINT) has outperformed PAVmed (PAVM) over the past year, losing 65.7% versus a loss of 88.8%. Over five years, PAVM leads with a -99.9% price change compared with -100.0% for SINT. PAVmed is the larger company by market cap ($9.1 million vs $8.3 million), about 1.1 times the size, while SiNtx Technologies is growing revenue faster (-64.7% vs -97.6%).
PAVmed converts more of its revenue into profit, with a net margin of 564.8% versus -1018.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PAVM | SINT |
|---|---|---|
| Share price | $1.14 | $1.10 |
| Market cap | $9.08M | $8.31M |
| 1-day change | -5.42% | -8.74% |
| YTD return | -82.88% | -71.50% |
| 1-year return | -88.77% | -65.73% |
| 5-year return | -99.93% | -99.99% |
| EPS (TTM) | $-7.33 | $-1.54 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $71.00K | $1.02M |
| Revenue growth (YoY) | -97.63% | -64.74% |
| Net income (latest FY) | $401.00K | $-10.36M |
| Gross margin | -207.04% | 45.28% |
| Operating margin | -30712.68% | -1053.14% |
| Net margin | 564.79% | -1018.07% |
| 52-week high | $28.44 | $4.46 |
| 52-week low | $1.10 | $1.09 |
| Distance from 52-week high | -96.01% | -75.34% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +3115.86% | +740.91% |
| Average volume | 23.70K | 48.13K |
| Shares outstanding | 8.00M | 7.56M |
| Employees | 41 | 32 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SINT has outperformed PAVM by 23.0 percentage points over the past year.
- PAVmed is more profitable, keeping 564.8 cents of every revenue dollar as net income versus -1018.1 cents for SiNtx Technologies.
- SiNtx Technologies grew revenue faster in its latest fiscal year (-64.74% vs -97.63%).
About PAVmed
PAVM stock →PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States.
Health Care · Medical/Dental Instruments · 41 employees
About SiNtx Technologies
SINT stock →Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE).
Health Care · Medical/Dental Instruments · 32 employees
PAVM vs SINT FAQ
Which is bigger, PAVmed or SiNtx Technologies?
PAVmed (PAVM) is larger, with a market capitalization of $9.08M compared with $8.31M for SiNtx Technologies (SINT).
Which stock has performed better over the past year, PAVM or SINT?
SINT returned -65.73% over the past 12 months, compared with -88.77% for PAVM (price return, excluding dividends). Past performance does not predict future results.
Are PAVmed and SiNtx Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.